Abstract
Recently, a specific Schwann cell type with pro-fibrotic and tissue regenerative properties has been identified that contributes to keloid formation. In the present study, we have reanalysed published single cell RNA sequencing (scRNAseq) studies of keloids, healthy skin and normal scars to reliably determine the specific gene expression profile of the keloid-specific Schwann cell type in more detail.
We were able to confirm the presence of the repair-like, pro-fibrotic Schwann cell type in the datasets of all three studies and identified a specific gene set for these Schwann cells. In contrast to keloids, in normal scars the number of Schwann cells was neither increased nor was their gene expression profile distinctly different from Schwann cells of normal skin. In addition, our bioinformatics analysis provided evidence for a role of transcription factors of the kruppel-like factor family and members of the immediate early response genes, in the de-differentiation process of keloidal Schwann cells.
Together, our analysis strengthens the role of the pro-fibrotic Schwann cell type in the formation of keloids. Knowledge on the exact gene expression profile of these Schwann cells will facilitate their identification in other organs and diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the FFG Grant (852748 and 862068; 2015-2019), the Vienna Business Agency ID 2343727, 2018-2020) and by the Aposcience AG under the direction of group leader HJA. MM was funded by the Sparkling Science Program of the Austrian Federal Ministry of Education, Science and Research (SPA06/055).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All ScRNAseq data are publicly accessible in NCBIs Gene Expression Omnibus (GSE181316, GSE163973), at the Genome Sequencing Archive (BioProject PRJCA003143) and under the following links: https://dom.pitt.edu/wp-content/uploads/2018/10/Skin_6Control_rawUMI.zip https://dom.pitt.edu/wp-content/uploads/2018/10/Skin_6Control_Metadata.zip
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi
https://dom.pitt.edu/wp-content/uploads/2018/10/Skin_6Control_rawUMI.zip
https://dom.pitt.edu/wp-content/uploads/2018/10/Skin_6Control_Metadata.zip
